EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
33 hedge funds and large institutions have $20.2M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
27% more funds holding
Funds holding: 26 → 33 (+7)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
33
Holding in Top 10
3
Calls
$393K
Puts
$21K
Top Buyers
| 1 | +$612K | |
| 2 | +$67.7K | |
| 3 | +$25K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$23.9K |
| 5 |
Morgan Stanley
New York
|
+$14.9K |
Top Sellers
| 1 | -$43.9K | |
| 2 | -$12.9K | |
| 3 | -$8.69K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.56K |
| 5 |
EWA
EP Wealth Advisors
Torrance,
California
|
-$4.51K |